In Narcolepsy (Uncontrollable daytime sleepiness) Narcolepsy is a sleep disorder that causes excessive daytime drowsiness. The affected person may experience excessive sleepiness, sleep paralysis, hallucinations, and in some cases episodes of cataplexy (partial or total loss of muscle control). Metadoop 200 Tablet stimulates the brain and makes you fully awake. It also relieves these abnormal symptoms and regulates the sleep cycle. This restores normal sleeping habits and improves your quality of life. You will feel more energetic and will be able to perform better in your daily activities.
Caution is advised when consuming alcohol with Metadoop 200 Tablet. Please consult your doctor.
Metadoop 200 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Metadoop 200 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Metadoop 200 Tablet may cause side effects which could affect your ability to drive. Patients with abnormal levels of sleepiness who take modafinil should be advised that their level of wakefulness may not return to normal, so they should avoid driving.
Metadoop 200 Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Metadoop 200 Tablet may not be needed in these patients. Please consult your doctor.
Metadoop 200 Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Metadoop 200 Tablet may be needed. Please consult your doctor.
If you miss a dose of Metadoop 200 Tablet, skip it and continue with your normal schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Psycormedies || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Kivonyx Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Consern Pharma Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vanprom Lifesciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Matias Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ryon Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Curelogic Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Semangat Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)